Study Information

Alliance Study ID: NCCTG-N99C7

NCT Study ID (ClinicalTrials.gov): NCT00030914

Disease or Cancer Type: Breast Cancer

Alliance Study Chair: Charles L. Loprinzi, MD

Status: COMPLETED


Study Description

RATIONALE: Medroxyprogesterone and venlafaxine may be effective in relieving hot flashes. It is not yet known whether venlafaxine is more effective than medroxyprogesterone in relieving hot flashes.

PURPOSE: Randomized phase III trial to compare the effectiveness of medroxyprogesterone with that of venlafaxine in treating women who are experiencing hot flashes.

Related Publications

For publications related to this and other clinical trials, visit the Alliance Publications Application.

Data Sources & Contacts

Related Alliance Trials